SCHEMBL8234459

SCHEMBL8234459

Cc1cccc(N(C)C(=O)CC(C)(C)C)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.38
GRM5 P41594 3/20 0.37
RAB9A P51151 3/20 0.37
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HPGD P15428 1/20 0.35
OPRM1 P35372 2/20 0.34
CCR1 P32246 1/20 0.33
CCR8 P51685 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GLA P06280 1/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
OPRD1 P41143 1/20 0.33
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13713493 0.82 OPRM1 (0.43) P2RX7GRM5RAB9AMEN1KMT2A
SCHEMBL21993660 0.79 TP53 (0.39) P2RX7GRM5RAB9AMEN1KMT2A
SCHEMBL13713005 0.79 RAB9A (0.40) P2RX7GRM5RAB9AMEN1KMT2A
SCHEMBL24864136 0.78 SMN1; SMN2 (0.41) P2RX7GRM5RAB9AMEN1KMT2A
SCHEMBL20909909 0.76 RAB9A (0.43) P2RX7GRM5RAB9AMEN1KMT2A
SCHEMBL15174120 0.76 RAB9A (0.43) P2RX7GRM5RAB9AMEN1KMT2A
SCHEMBL852406 0.75 PAX8 (0.42) P2RX7GRM5RAB9AMEN1KMT2A
SCHEMBL9665431 0.75 RAB9A (0.42) P2RX7GRM5RAB9AMEN1KMT2A
SCHEMBL13606319 0.74 GRM5 (0.42) P2RX7GRM5RAB9ACCR1CCR8
SCHEMBL6482424 0.72 RAB9A (0.40) P2RX7GRM5RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007141473-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL] -L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS ASTRAZENECA AB (SE) 2007-12-13 WO disclosed